Anti-SOX11 抗体 [EPR20457]
Anti-SOX11 antibody [EPR20457]
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
3
(2 Reviews)
|
(6 Publications)
Rabbit Recombinant Monoclonal SOX11 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 6 publications.
別名を表示する
Transcription factor SOX-11, SOX11
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX11 antibody [EPR20457] (AB229185)
Immunohistochemical analysis of paraffin-embedded human mantle cell lymphoma tissue labeling SOX11 with ab229185 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Nucleus staining in human mantle cell lymphoma (PMID : 19880788. PMID : 17934069) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX11 antibody [EPR20457] (AB229185)
Immunohistochemical analysis of paraffin-embedded human glioma tissue labeling SOX11 with ab229185 at 1/250 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Nucleus staining on human glioma (PMID : 15583815.) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- WB
Supplier Data
Western blot - Anti-SOX11 antibody [EPR20457] (AB229185)
Exposure time : Lane 1 : 1 minute, Lane 2 : 3 minutes.
Blocking/Dilution buffer : 5% NFDM/TBST.
The molecular weight observed is phosphorylated form, consistent with what has been described in the literature. (PMID : 19880779, PMID : 29973868).
All lanes:
Western blot - Anti-SOX11 antibody [EPR20457] (ab229185) at 1/1000 dilution
Lane 1:
SH-SY5Y (human neuroblastoma cell line from bone marrow) whole cell lysate at 20 µg
Lane 2:
Human fetal brain lysate at 10 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 47 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-SOX11 antibody [EPR20457] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (6)
Recent publications for all applications. Explore the full list and refine your search
International dental journal 75:100872 PubMed40543136
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 638:469-478 PubMed39814878
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging 16:3896-3914 PubMed38407972
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed36551589
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 22:31 PubMed35033084
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell biochemistry and function 37:608-617 PubMed31502671
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com